Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy. Shallis RM, Pucar D, Perincheri S, Gore SD, et al. Ann Hematol 2022;101:1145-1147.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shallis RM, Pucar D, Perincheri S, Gore SD, et al. Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy. Ann Hematol 2022;101:1145-1147.
PMID: 34686913